Table 3.

Effect of salt substitute intervention on all-cause mortality and cardiovascular disease mortality among all and hypertensive participants.

Cause of death	HRrude	P	HRadjust1	P	HRadjust2	P
All participants
All-cause	0.81 (0.46–1.42)	0.463	0.80 (0.46–1.40)	0.434	0.75 (0.42–1.32)	0.311
CVD	0.58 (0.26–1.32)	0.194	0.48 (0.21–1.13)	0.094	0.43 (0.18–1.02)	0.056
Heart disease	1.28 (0.35–4.79)	0.707	1.05 (0.27–4.12)	0.945	0.97 (0.24–3.88)	0.961
Stroke	0.35 (0.11–1.07)	0.066	0.29 (0.09–0.94)	0.039	0.26 (0.08–0.84)	0.024
Hypertensive participants
All-cause	0.73 (0.41–1.30)	0.284	0.71 (0.40–1.28)	0.252	0.68 (0.38–1.22)	0.195
CVD	0.49 (0.21–1.15)	0.103	0.41 (0.17–0.99)	0.049	0.38 (0.16–0.92)	0.032
Heart disease	0.98 (0.25–3.92)	0.976	0.79 (0.19–3.37)	0.750	0.77 (0.18–3.34)	0.726
Stroke	0.33 (0.11–1.02)	0.055	0.28 (0.09–0.91)	0.034	0.25 (0.08–0.82)	0.022

CVD, Cardiovascular disease; adjust1, Adjusted with baseline age; adjust2, Adjusted with baseline age and alcohol drinking status.